Cardiac PET Imaging

Cardiac PET Imaging Overview

  • MPI Imaging

    • Available for over 30 years.

    • Duration of Rest/Stress MPI procedure: 3-4 hours.

    • Disadvantages include:

    • Attenuation

    • Motion artefacts

    • Processing errors

    • Limitations in identifying multivessel disease with stress agents

Advancements in Cardiac PET

  • Initially available exclusively for oncology patients.

  • Now accessible for cardiac patients.

  • Advantages of PET technology include:

    • Improved image quality

    • Enhanced diagnostic accuracy

    • Faster acquisition times compared to MPI

Principles of Coincidence Detection

  • Mechanism of PET:

    • Positron (β+) emitted from 13N atomic nucleus travels through a medium, losing energy and slowing down.

    • Interaction occurs with an electron (e−), resulting in annihilation.

    • Annihilation generates 2 photons traveling 180° apart, each with an energy of 511 keV.

    • Photons are detected as coincidences in the PET camera's detector ring.

    • Definition of PET: Positron Emission Tomography.

Normal Myocardial Perfusion Images

  • Visual quality comparisons of different positron-emitting flow tracers:

    • 13N-ammonia: Excellent image quality.

    • 82Rubidium: Good image quality.

    • 15O-water: Limited visual analysis due to lower count density.

Radiotracers

Ammonia-13 (N-13)

  • History: Utilized for around 20 years.

  • Cyclotron required for production.

  • Half-life: 9.96 minutes.

  • Behavior in bloodstream:

    • In the extravascular space, it exists as NH4+.

    • NH3 is lipid-soluble; crosses membranes into myocytes.

    • Converted to NH4+ and trapped in association with glutamine.

  • Disadvantages:

    • 10% lower retention in the lateral wall, resulting in false positives.

    • Prominent liver activity can obscure inferior wall images.

Rubidium-82 (Rb-82)

  • Potassium analog, produced by strontium-82 (Sr-82) which has a half-life of 25.5 days.

  • Rb-82 half-life: 75 seconds; requires onsite generator availability.

  • Recent regulatory changes allowed reintroduction.

  • Advantages:

    • Rapid acquisition times possible; entire protocol completion in 28-30 minutes including stress/rest phases.

Sample PET Procedure

  • Injection of 55-60 mCi Rb-82.

  • Gated Rest acquisition lasting approximately 7 minutes.

  • Vasodilator Stress test lasting about 7 minutes, followed by another injection of Rb-82.

  • Second gated stress acquisition lasting another 7 minutes.

Indications for Cardiac PET

  • Who should receive cardiac PET imaging?

    • Patients with equivocal SPECT stress tests.

    • Obese patients.

    • Patients with high suspicion of coronary artery disease (CAD).

    • Patients with known CAD.

    • Assessment of myocardial viability.

    • Evaluation of cardiac sarcoidosis.

Case Evaluations

13N-Ammonia PET/CT and Coronary Angiography

  • Example of a 62-year-old type 2 diabetic:

    • Stress images reveal a moderately decreased perfusion defect in lateral, extending to the inferolateral region of the left ventricle, which is reversible in rest images.

    • Corresponding coronary angiography indicates an occluded marginal branch of the left circumflex artery and stenoses in the proximal left anterior descending artery and mid right coronary artery.

Myocardial Perfusion Study

  • Example of a 61-year-old patient with arterial hypertension and type 2 diabetes:

    • Stress images show reduced perfusion defect in mid-to-distal anterior, anteroseptal, and apical regions of the left ventricle, which is reversible at rest.

    • Uptake preserved in lateral and inferior regions.

    • Integrated PET/CT images demonstrate accurate coregistration of PET signal with CT-contrast images, allowing for enhanced anatomical mapping.

Viability Assessment

  • Importance of assessing myocardial viability in patients with Congestive Heart Failure (CHF).

  • Enhanced understanding of cardiac function correlates with significant morbidity and mortality.

  • Metabolic considerations:

    • Normal myocytes rely on fatty acid metabolism.

    • Damaged myocytes switch to glucose metabolism.

FDG Imaging

Characteristics of Fluorodeoxyglucose (FDG)

  • FDG is fluorine-labeled 2-deoxyglucose.

  • Produced through cyclotron.

  • Half-life: 109.8 minutes.

  • Positron energy decay: transforms to O-18 (635 keV).

  • Provides the highest spatial resolution images among commonly used radionuclides.

Metabolic Mechanism

  • Glucose analog facilitated by glucose-specific transporters into myocytes via diffusion.

  • When phosphorylated to FDG-6-P, it becomes trapped within the cell.

Viability Evaluation Components

  • Two main components assessed:

    • Resting perfusion

    • Resting metabolism

    • Presence of viable tissue is indicated by:

    • Active metabolism with absent perfusion.

    • Non-viable tissue is characterized by:

    • Absent perfusion with absent metabolism.

    • Patients should be stimulated with oral glucose to activate glucose metabolism (glucose loading).